Profiling posttransplant circulating antibodies in kidney transplantation using donor endothelial cells
Transplantation, 2012•journals.lww.com
Background. Pathogenesis of antibody (Ab) responses to transplant are yet not well defined.
This study aimed to detect and to analyze posttransplant circulating allo-Abs reacting toward
graft endothelial cells (ECs) using primary EC cultures prospectively isolated from the
transplant donor at the time of transplantation. Methods. This study shows a retrospective
analysis performed using a dedicated EC crossmatch (ECXM) assay that we developed for
the experimental assessment of donor-specific EC-reactive Abs. Donor-specific ECXM was …
This study aimed to detect and to analyze posttransplant circulating allo-Abs reacting toward
graft endothelial cells (ECs) using primary EC cultures prospectively isolated from the
transplant donor at the time of transplantation. Methods. This study shows a retrospective
analysis performed using a dedicated EC crossmatch (ECXM) assay that we developed for
the experimental assessment of donor-specific EC-reactive Abs. Donor-specific ECXM was …
Abstract
Background.
Pathogenesis of antibody (Ab) responses to transplant are yet not well defined. This study aimed to detect and to analyze posttransplant circulating allo-Abs reacting toward graft endothelial cells (ECs) using primary EC cultures prospectively isolated from the transplant donor at the time of transplantation.
Methods.
This study shows a retrospective analysis performed using a dedicated EC crossmatch (ECXM) assay that we developed for the experimental assessment of donor-specific EC-reactive Abs. Donor-specific ECXM was performed by flow cytometry on posttransplant sera (n= 256) from an historical cohort of 22 kidney allograft recipients.
Results.
In this study, we show that 27.3%(6/22) of recipients have a positive ECXM that strictly correlates (100%, 6/6) with the presence of anti-human leukocyte antigen (HLA) Abs posttransplantation. ECXM identifies both donor-specific Abs (DSA; 50%) and non-DSA (50%) reactive to EC. DSA and non-DSA are mostly IgG1 and exhibit peak titers ranging from 1/8 to 1/1024. ECXM indicates that DSA correspond to anti-HLA class II Abs; this immunization is late (M3-M60) but persistent (still detected at M60). In contrast, non-DSA are non-HLA-type Abs reacting with third-party EC and reflecting an early but transient immunization (ended at M3-M12). Our findings demonstrate selective regulatory pathways initiated by anti-HLA class II and non-DSA in graft EC reflected by CCR4 and interleukin 1β up-regulation, respectively.
Conclusions.
We provide evidence that circulating Abs in HLA-sensitized transplant recipients include both DSA and non-HLA/non-DSA able to bind to graft EC and induce specific gene transcription.
Lippincott Williams & Wilkins